Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
DSP Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited8.79311535592266.7323
Domestic EquitiesIPCA Laboratories Limited8.55011696381259.3597
Domestic EquitiesCipla Limited8.05991813462244.4909
Domestic EquitiesLaurus Labs Limited6.49941832618197.1530
Domestic EquitiesSai Life Sciences Limited5.89801792251178.9115
Domestic EquitiesGland Pharma Limited5.5305920673167.7650
Domestic EquitiesApollo Hospitals Enterprise Limited5.0219194767152.3370
Domestic EquitiesPfizer Limited3.3484200644101.5700
Domestic EquitiesAlembic Pharmaceuticals Limited3.34841428180101.5722
Domestic EquitiesVijaya Diagnostic Centre Limited3.098093553093.9740
Domestic EquitiesCohance Lifesciences Limited3.0370297221392.1237
Domestic EquitiesKovai Medical Center and Hospital Limited2.878716515687.3229
Domestic EquitiesProcter & Gamble Health Limited2.573315928878.0591
Domestic EquitiesIndoco Remedies Limited2.1562323347465.4067
Domestic EquitiesConcord Biotech Limited1.998649668860.6257
Domestic EquitiesEmcure Pharmaceuticals Limited1.862138808756.4861
Domestic EquitiesICICI Lombard General Insurance Company Limited1.513324141345.9047
Domestic EquitiesNephrocare Health Services Limited1.243063498337.7053
Domestic EquitiesAarti Drugs Limited1.031085215531.2741
Domestic EquitiesUnichem Laboratories Limited0.972485206329.4984
Domestic EquitiesAlkem Laboratories Limited0.69413733421.0545
Domestic EquitiesCorona Remedies Limited0.612011697018.5655
Domestic EquitiesMedplus Health Services Limited0.536719207816.2805
Domestic EquitiesJupiter Life Line Hospitals Limited0.39159411711.8757
Domestic EquitiesLaxmi Dental Limited0.17802804015.3997
Total 79.8256 2421.4482
Cash & Cash Equivalents and Net AssetsTREPS / Reverse Repo Investments1.1450 34.7326
Cash & Cash Equivalents and Net AssetsNet Receivables/Payables-0.0817 -2.4796
Total 1.0633 32.2530
Overseas EquitiesGlobus Medical Inc7.6938268800233.3853
Overseas EquitiesIllumina Inc6.4668160400196.1644
Overseas EquitiesIntuitive Surgical Inc2.83351876885.9506
Overseas EquitiesAbbott Laboratories1.10243160033.4408
Overseas EquitiesGrail Inc0.139487334.2281
Total 18.2358 553.1692
Overseas Mutual Fund UnitsGlobal X Funds - Global X Genomics & Biotechnology ETF0.87546125026.5539
Total 0.8754 26.5539
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.